Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Rocky9 who wrote (8844)	9/15/2005 12:12:34 PM
From: Biomaven	Read Replies (1) \| Respond to of 10280

Plus I think that there may need to be additional stocking, not use of current stocking. We might be able to work this out. They ended last quarter with 9.5 weeks of inventory, and expected a reduction to four to six weeks by year end. The key question is what "9.5 weeks of inventory" actually met - was it the run-rate at the end of the period, or the average for the quarter? If it was end-of-period run rate (which would make most sense), then that meant about 700k scripts worth, or 7 weeks at the current run-rate of 100k/week. That would mean likely inventory stays about flat figuring that run-rate is increasing and they were talking about end-of-year not end of Q3 for the 4-6 weeks level. Comments? Peter